Janssen, Samsung Subsidiary Drop Suit Over Remicade Copy
A Johnson & Johnson subsidiary dropped its infringement lawsuit against Samsung Bioepis Co. Ltd. over a patent on its arthritis-treating biologic Remicade, with the parties agreeing in New Jersey federal court...To view the full article, register now.
Already a subscriber? Click here to view full article